Clinical Trial Update: A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments [Phase 4]

View source ↗

Summary

Phase 4 continued-access study by Gilead Sciences provides ongoing access to the study drug for children and adolescents who have completed prior HIV treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 4 | Status: RECRUITING